Pham Phuong Chi, Konanur Ventakaram Raghu, Pham Jimmy, Sidhu Harpreet, Bader Nada, Pham Phuong Mai, Pham Phuong Thu
Olive View-UCLA Medical Center, Division of Nephrology, Sylmar, CA, USA.
Greater Los Angeles Veterans Administration, Sepulveda Ambulatory Care Center, Los Angeles, CA, USA.
Case Rep Med. 2021 May 10;2021:9962624. doi: 10.1155/2021/9962624. eCollection 2021.
Hyperphosphatemia may arise from various conditions including exogenous ingestion, extracellular shifts due to cell death or alterations in acid-base status, increased bone resorption, hormonal dysregulations leading to reduced renal excretion, reduced kidney function, or faulty measurement techniques. We herein present a case of a young pregnant woman who presented with mild acute kidney injury (AKI), invasive mucormycosis receiving liposomal amphotericin, and hyperphosphatemia out of proportion to the degree of kidney injury. While the patient was given routine phosphate-binding agent by her primary care team for presumed AKI-associated hyperphosphatemia, a full investigation by the renal consulting team for contributing factors other than kidney injury revealed that she actually had pseudohyperphosphatemia associated with the use of liposomal amphotericin. Erroneous treatment of pseudohyperphosphatemia may have been detrimental to this pregnant patient. A literature review for conditions associated with pseudohyperphosphatemia other than the use of liposomal amphotericin will be discussed.
高磷血症可能由多种情况引起,包括外源性摄入、因细胞死亡或酸碱状态改变导致的细胞外转移、骨吸收增加、导致肾脏排泄减少的激素失调、肾功能减退或测量技术错误。我们在此报告一例年轻孕妇,她出现轻度急性肾损伤(AKI)、接受脂质体两性霉素治疗的侵袭性毛霉病以及与肾损伤程度不相称的高磷血症。虽然患者的初级保健团队因推测与AKI相关的高磷血症而给予其常规的磷结合剂,但肾脏咨询团队对肾损伤以外的促成因素进行的全面调查显示,她实际上患有与使用脂质体两性霉素相关的假性高磷血症。对假性高磷血症的错误治疗可能对这位孕妇有害。本文将讨论除使用脂质体两性霉素外与假性高磷血症相关情况的文献综述。